Kalytera announces submission of patent application to the U.S. Patent and Trademark Office – New Cannabidiol (CDB) composition
Wednesday, May 29, 2019 DrugName : cannabidiol Kalytera Therapeutics, Inc. announced that it has filed a provisional patent application with the
Read More